Peptonic signs license agreement with Prima Lab regarding menopause test
PEPTONIC Medical AB today announced that the company has signed a license agreement with Swiss medical device company Prima Lab SA for the sale of self-tests for measurement of FSH hormone in Sweden.The agreement means that Peptonic gets the right to sell Prima Lab's self-test for FSH hormone under its own brand VagiVital® in Sweden, with a planned launch in early 2024. Today, about one million women in Sweden are in menopause. Menopause brings problems to varying degrees such as vaginal dryness, sweating, hot flushes and more subtle symptoms such as concentration and memory difficulties.